Living-donor liver transplantation for homozygous familial hypercholesterolemia from a donor with heterozygous hypercholesterolemia

Transplant International

Volumn 16, Issue 4, 2003, Pages 276-279

  Shirahata, Yasuhiro ^a   Ohkohchi, Nobuhiro ^b   Kawagishi, Naoki ^a   Syouji, Masaru ^a   Tsukamoto, Sigeki ^a   Sekiguchi, Satoru ^a   Koyamada, Nozomisa ^a   Oikawa, Sinichi ^c   Satomi, Susumu ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Donor with heterozygous hypercholesterolemia; Homozygous familial hypercholesterolemia; Liver transplantation

Indexed keywords

CHOLESTEROL;

ARTICLE; CASE REPORT; CHILD; FAMILIAL HYPERCHOLESTEROLEMIA; FATHER; HETEROZYGOTE; HISTOPATHOLOGY; HOMOZYGOTE; HUMAN; HUMAN TISSUE; LIVER TRANSPLANTATION; LIVING DONOR; MALE; PRIORITY JOURNAL;

CHILD, PRESCHOOL; CHOLESTEROL; FATHERS; HEPATIC ARTERY; HETEROZYGOTE DETECTION; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; LIVER TRANSPLANTATION; LIVING DONORS; MALE; POSTOPERATIVE PERIOD;

EID: 0037641223     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2003.tb00299.x     Document Type: Article

References (14)

1. Bambauer R (1996) Low-density lipoprotein-apheresis in two patients with extremely elevated lipoprotein levels. J Clin Apheresis 11:78
2. Bilheimer DW, Goldstein JL, Grundy SM (1984) Liver transplantation to provide low-density-lipoprotein receptors and lower plasma cholesterol in a child with homozygous familial hypercholesterolemia. N Engl J Med 311:1658-1664
3. East C, Grundy SM, Bilheimer DW (1986) Normal cholesterol levels with lovastatin (mevinolin) therapy in a child with homozygous familial hypercholesterolemia following liver transplantation. JAMA 256:2843-2848
4. Etienne S, Laura U, Carl H, Jean O (1993) Liver transplantation for familial hypercholesterolemia before the onset of cardiovascular complications. Transplantation 55:432-433
5. Grossman M, Raper SE, Kozarsky K (1994) Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolemia. Nat Genet 6:335-341
6. Illingworth DR, Bacon S (1987) Hypolipidemic effects of HMG-CoA reductase inhibitors in patients with hypercholesterolemia. Am J Cardiol 60:33
7. Lopez-Santamaria M, Migliazza L, Gamez M, Murcia J, Diaz-Gonzalez M, Camarena C, Hierro L, De la Vega A, Frauca E, Diaz M, Jara P, Tovar J (2000) Liver transplantation in patients with homozygotic familial hypercholesterolemia previously treated by end-to-side portocaval shunt and ileal bypass. J. Pediatr Surg 35:630-633
8. Mabuchi H (1981) Effect of an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase on serum lipoproteins and ubiquinone-10 levels in patients with familial hypercholesterolemia. N Engl J Med 305:478
9. Mabuchi H, et al (1987) A new low density lipoprotein apheresis system using two dextransulfate cellulose columns in an automated column regenerating unit (LDL continuous apheresis). Atherosclerosis 68:19
10. Revell SP, Noble-Jamieson G, Johnston P, Rasmussen A, Jamieson N, Barnes ND (1995) Liver transplantation for homozygous familial hypercholesterolemia. Arch Dis Child 73:456-458
11. Shaw BW, Bahnson HT, Hardesty RL (1985) Combined transplantation of the heart and the liver. Ann Surg 202:667
12. Starzl TE, Putnam CW, Chase HP (1973) Portocaval shunt in hyperlipoproteinaemia. Lancet 2:940-944
13. Starzl TE, Putnam CW, Koep LJ (1978) Portocaval shunt and hyperlipidemia. Arch Surg 113:71-74
14. Starzl TE, Bilheimer DW, Bahnson HT (1984) Heart-liver transplantation in a patient with familial hypercholesterolemia. Lancet 1:1382